(1)
Janus Kinase Inhibitors in Rheumatoid Arthritis-Associated Interstitial Lung Disease: Where Do We Stand and What May Be the Future?. Reumatismo 2025, 77 (2). https://doi.org/10.4081/reumatismo.2025.1754.